focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,772.00
Bid: 1,771.50
Ask: 1,772.00
Change: -11.50 (-0.64%)
Spread: 0.50 (0.028%)
Open: 1,773.50
High: 1,779.00
Low: 1,764.50
Prev. Close: 1,783.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

DIRECTOR DEALINGS: Glaxo Executives Acquire Shares, ADSs

Tue, 15th Apr 2014 15:08

LONDON (Alliance News) - GlaxoSmithKline PLC Tuesday said a group of executives, including Chief Executive Andrew Witty, acquired shares and American Depositary Shares under the 2009 deferred annual bonus plan at a price of 1581.50 pence per share and USD53.42 per ADS each following a dividend reinvestment.

Details are as follows.

Sir Andrew Witty

Acquisition of 2,101 Ordinary Shares under the personal contribution element of the Plan.

 

 

 

Acquisition of 2,101 Ordinary Shares under the matching element of the Plan (Company contribution).

 

 

Mr S Dingemans

Acquisition of 924 Ordinary Shares under the personal contribution element of the Plan.

 

 

 

Acquisition of 924 Ordinary Shares under the matching element of the Plan (Company contribution).

 

 

Dr M M Slaoui

Acquisition of 791 ADSs under the personal contribution element of the Plan.

 

 

 

Acquisition of 791 ADSs under the matching element of the Plan (Company contribution).

 

 

Mr S M Bicknell

Acquisition of 210 Ordinary Shares under the personal contribution element of the Plan.

 

 

 

Acquisition of 210 Ordinary Shares under the matching element of the Plan (Company contribution).

 

 

Mrs D P Connelly

Acquisition of 153 ADSs under the personal contribution element of the Plan.

 

 

 

Acquisition of 153 ADSs under the matching element of the Plan (Company contribution).

 

 

Mr R G Connor

Acquisition of 236 Ordinary Shares under the personal contribution element of the Plan.

 

 

 

Acquisition of 236 Ordinary Shares under the matching element of the Plan (Company contribution).

 

 

Mr S A Hussain

Acquisition of 119 Ordinary Shares under the personal contribution element of the Plan.

 

 

 

Acquisition of 119 Ordinary Shares under the matching element of the Plan (Company contribution).

 

 

Mr W C Louv

 

Acquisition of 191 ADSs under the personal contribution element of the Plan.

 

 

 

Acquisition of 191 ADSs under the matching element of the Plan (Company contribution).

 

 

Mr D S Redfern

Acquisition of 449 Ordinary Shares under the personal contribution element of the Plan.

 

 

 

Acquisition of 449 Ordinary Shares under the matching element of the Plan (Company contribution).

 

 

Ms C Thomas 

Acquisition of 338 Ordinary Shares under the personal contribution element of the Plan.

 

 

 

Acquisition of 338 Ordinary Shares under the matching element of the Plan (Company contribution).

 

 

Mr P C Thomson

Acquisition of 69 Ordinary Shares under the personal contribution element of the Plan.

 

 

 

Acquisition of 69 Ordinary Shares under the matching element of the Plan (Company contribution).

 

 

Mr D E Troy

Acquisition of 350 ADSs under the personal contribution element of the Plan.

 

 

 

Acquisition of 350 ADSs under the matching element of the Plan (Company contribution).

 

 

Dr P J T Vallance

Acquisition of 986 Ordinary Shares under the personal contribution element of the Plan.

 

 

Acquisition of 986 Ordinary Shares under the matching element of the Plan (Company contribution).

 

 

Ms E Walmsley

Acquisition of 544 Ordinary Shares under the personal contribution element of the Plan.

 

 

Acquisition of 544 Ordinary Shares under the matching element of the Plan (Company contribution).

 



Shares in the global healthcare company were trading at 1,549.00 pence up 0.4% Tuesday.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright © 2014 Alliance News Limited. All Rights Reserved.

More News
15 Sep 2023 21:52

GSK's Ojjaara approved in US for myelofibrosis patients with anaemia

(Alliance News) - GSK PLC on Friday said Ojjaara, also known as momelotinib, has been approved in the US and the "first and only" treatment indicated for myelofibrosis patients with anaemia.

Read more
11 Sep 2023 08:24

Japan accepts GSK's regulatory filing for momelotinib for blood cancer

(Alliance News) - GSK PLC on Monday reported regulatory progress for momelotinib, as Japan's Ministry of Health, Labour & Welfare accepted a review for the blood cancer-focused drug.

Read more
11 Sep 2023 07:54

LONDON BRIEFING: Restaurant Group sells Frankie & Benny's and Chiquito

(Alliance News) - Stocks in London are called higher on Monday, ahead of a busy week of interest rate decisions and economic data.

Read more
6 Sep 2023 09:32

LONDON BROKER RATINGS: Shore says 'buy' B&M; Peel Hunt likes Halfords

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
4 Sep 2023 06:00

More UK babies to need hospital treatment over delay of GSK's RSV jab

(Alliance News) - The nation's top children's doctor has warned a delay on a new vaccine to combat respiratory syncytial virus, or RSV, will mean more babies and infants will need hospital treatment this winter.

Read more
1 Sep 2023 09:11

GSK antibody accepted for Japan review, Goldman Sachs reduces stake

(Alliance News) - GSK PLC on Friday said a new drug application for its monoclonal antibody mepolizumab has been accepted for review by the Japanese government.

Read more
1 Sep 2023 07:49

LONDON BRIEFING: Stocks seen higher; UK house prices continue to fall

(Alliance News) - Stocks in London are set to open higher on Friday as markets looked ahead to a data-heavy day.

Read more
1 Sep 2023 07:12

Japan considering GSK's Nucala drug for sinusitis treatment

(Sharecast News) - Japanese regulators are reviewing a new drug application for GSK's Nucala treatment to be used for the treatment of form of adult sinusitis, the biopharma giant announced on Friday.

Read more
23 Aug 2023 12:10

LONDON MARKET MIDDAY: Stocks rise but pound slumps on sub-par UK data

(Alliance News) - Stocks in Europe were on the up heading into Wednesday afternoon, with equity markets in a confident mood on the eve of the Jackson Hole central banking event, shaking off tepid economic data which hurt the pound and euro.

Read more
23 Aug 2023 08:17

GSK gets positive results from shingles trial of Shingrix in China

(Alliance News) - GSK PLC on Wednesday celebrated positive results from the first-ever efficacy trial of its preventative shingles treatment, Shingrix, in China.

Read more
23 Aug 2023 07:04

GSK reports positive results from shingles vaccine trials in China

(Sharecast News) - GSK reported significant positive findings from its first efficacy trial of the 'Shingrix' shingles vaccine in China on Wednesday.

Read more
22 Aug 2023 13:09

UK's Wood Group raises profit forecast on contract wins; shares rise

CFO David Kemp to retire

*

Read more
21 Aug 2023 22:37

US FDA approves Pfizer's maternal RSV vaccine to protect infants

Aug 21 (Reuters) - The U.S. Food and Drug Administration on Monday approved Pfizer's respiratory syncytial virus (RSV) vaccine for use in women during the middle of the third trimester of pregnancy to protect their babies.

Read more
17 Aug 2023 19:53

Charity says HIV drug deal with GSK's ViiV on ice over price secrecy

(Alliance News) - The Doctors Without Borders, or MSF, charity said Thursday a deal aimed to bring long-term preventative HIV treatment to vulnerable populations was on hold after the drugmaker imposed pricing confidentiality.

Read more
17 Aug 2023 11:56

LONDON MARKET MIDDAY: Stocks down over US rate hike worries

(Alliance News) - Stock prices in Europe were lower at midday on Thursday, after the US Federal Reserve warned that a further interest rate hike may be on the cards.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.